Dr Raj Sengupta is a Consultant Rheumatologist and Lead for Rheumatology and Axial Spondyloarthritis (axSpA) at The Royal National Hospital for Rheumatic Diseases, Bath (RNRHD).

He is a member of the British Society for Rheumatology (BSR) axSpA Biologics Guidelines Committee and a member of Assessment of Spondyloarthritis International Society (ASAS). He has represented the BSR at the NICE TA383 appraisal for anti-TNF in axSpA. Dr Sengupta is a medical advisor for the National Axial Spondyloarthritis Society (NASS) and is one of the founder members of the British Society for SpondyloArthritis (BRITSpA). Dr Sengupta was the recipient of the 2016 NASS Patients Choice award for the Best Care provided by a Rheumatologist.

Dr Sengupta is the principal investigator in several national and international clinical trials in axSpA. He has a number of peer reviewed publications on axSpA. Dr Sengupta has been an invited speaker on axSpA at several national and international meetings.